• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新的疫苗接种策略。

: A New Strategy for Vaccination.

作者信息

Azizpour Maryam, Hosseini Seyyed Davood, Jafari Parvaneh, Akbary Neda

机构信息

Department of Microbiology, Arak branch, Islamic Azad University, Arak, Iran.

Razi Vaccine and Serum Research Institute, Arak Branch, Arak, Iran.

出版信息

Avicenna J Med Biotechnol. 2017 Oct-Dec;9(4):163-168.

PMID:29090064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5650732/
Abstract

Needle free vaccines have a several advantages and very attractive way for vaccination. In a body, mucosal surfaces provide a universal entry portal for all the known and emerging infectious pathogenic microbes. Therefore, it seems, vaccination strategies need to be reorganized for vaccines that are hindering the entry capability of pathogenic microbes through mucosal surfaces. Lactic acid Bacteria (LAB) are widely used in the food industry and at the present, used as delivery vehicles for biological investigations. In this review, we summarized the Results of several studies which () used as a live vector for vaccines. These bacteria are considered as promising candidates for heterologous expression of proteins and biotechnological usage. LAB are considered as promising candidates for heterologous expression of proteins and biotechnological usage. The results showed that these bacteria have an ability to deliver antigen to immune system. Therefore, developing mucosal live vaccines using lactic acid bacterium, , as an antigen delivery vector, is an attractive alternative choice and a safer vaccination strategy against pathogens.

摘要

无针疫苗具有诸多优势,是一种非常有吸引力的疫苗接种方式。在人体中,黏膜表面为所有已知的和新出现的感染性致病微生物提供了一个通用的进入门户。因此,对于那些阻碍致病微生物通过黏膜表面进入能力的疫苗,似乎需要重新组织疫苗接种策略。乳酸菌(LAB)在食品工业中广泛应用,目前也被用作生物学研究的递送载体。在这篇综述中,我们总结了几项将其用作疫苗活载体的研究结果。这些细菌被认为是蛋白质异源表达和生物技术应用的有前途的候选者。乳酸菌被认为是蛋白质异源表达和生物技术应用的有前途的候选者。结果表明,这些细菌有能力将抗原递送至免疫系统。因此,开发以乳酸菌作为抗原递送载体的黏膜活疫苗,是一种有吸引力的替代选择,也是一种针对病原体的更安全的疫苗接种策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b168/5650732/7fbb2182526f/AJMB-9-163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b168/5650732/7fbb2182526f/AJMB-9-163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b168/5650732/7fbb2182526f/AJMB-9-163-g001.jpg

相似文献

1
: A New Strategy for Vaccination.一种新的疫苗接种策略。
Avicenna J Med Biotechnol. 2017 Oct-Dec;9(4):163-168.
2
[Progress on lactococcus lactis expressing heterologous antigens as live mucosal vaccines].[乳酸乳球菌作为活黏膜疫苗表达异源抗原的研究进展]
Wei Sheng Wu Xue Bao. 2006 Aug;46(4):680-3.
3
Plasmid Replicons for the Production of Pharmaceutical-Grade pDNA, Proteins and Antigens by Cell Factories.用于细胞工厂生产药用级质粒DNA、蛋白质和抗原的质粒复制子
Int J Mol Sci. 2021 Jan 30;22(3):1379. doi: 10.3390/ijms22031379.
4
Heterologous protein production and delivery systems for Lactococcus lactis.用于乳酸乳球菌的异源蛋白生产和递送系统。
Genet Mol Res. 2003 Mar 31;2(1):102-11.
5
Novel Strategies for Efficient Production and Delivery of Live Biotherapeutics and Biotechnological Uses of : The Lactic Acid Bacterium Model.高效生产和递送活性生物治疗药物的新策略以及乳酸菌模型的生物技术应用
Front Bioeng Biotechnol. 2020 Nov 4;8:517166. doi: 10.3389/fbioe.2020.517166. eCollection 2020.
6
Neutralizing-antibody-mediated protection of chickens against infectious bursal disease via one-time vaccination with inactivated recombinant Lactococcus lactis expressing a fusion protein constructed from the RCK protein of Salmonella enterica and VP2 of infectious bursal disease virus.通过单次免疫表达沙门氏菌 RCK 蛋白和传染性法氏囊病病毒 VP2 融合蛋白的重组 Lactococcus lactis 菌,实现对鸡的抗传染性法氏囊病的中和抗体介导的保护。
Microb Cell Fact. 2019 Jan 31;18(1):21. doi: 10.1186/s12934-019-1061-9.
7
Heterologous expression of Brucella abortus GroEL heat-shock protein in Lactococcus lactis.流产布鲁氏菌GroEL热休克蛋白在乳酸乳球菌中的异源表达。
Microb Cell Fact. 2006 Mar 23;5:14. doi: 10.1186/1475-2859-5-14.
8
Cell Wall Anchoring of the Campylobacter Antigens to Lactococcus lactis.弯曲杆菌抗原与乳酸乳球菌的细胞壁锚定
Front Microbiol. 2016 Feb 18;7:165. doi: 10.3389/fmicb.2016.00165. eCollection 2016.
9
Lactic acid bacteria--20 years exploring their potential as live vectors for mucosal vaccination.乳酸菌——探索其作为黏膜疫苗活载体潜力的20年
Appl Microbiol Biotechnol. 2015 Apr;99(7):2967-77. doi: 10.1007/s00253-015-6498-0. Epub 2015 Mar 10.
10
Heterologous expression of carcinoembryonic antigen in Lactococcus lactis via LcsB-mediated surface displaying system for oral vaccine development.通过 LcsB 介导的表面展示系统在 Lactococcus lactis 中异源表达癌胚抗原用于口服疫苗开发。
J Microbiol Immunol Infect. 2016 Dec;49(6):851-858. doi: 10.1016/j.jmii.2014.11.009. Epub 2014 Nov 22.

引用本文的文献

1
Engineering T7 RNA polymerase-cascaded systems controlled by nisin and theophylline for protein overexpression and targeted gene mutagenesis in .构建由乳链菌肽和茶碱控制的T7 RNA聚合酶级联系统用于蛋白质过表达和靶向基因诱变。
Synth Syst Biotechnol. 2025 Jun 22;10(4):1150-1159. doi: 10.1016/j.synbio.2025.06.008. eCollection 2025 Dec.
2
Novel Approaches in Establishing Chemical Food Safety Based on the Detoxification Capacity of Probiotics and Postbiotics: A Critical Review.基于益生菌和后生元解毒能力建立化学食品安全的新方法:批判性综述
Probiotics Antimicrob Proteins. 2025 Jun 13. doi: 10.1007/s12602-025-10615-1.
3

本文引用的文献

1
Studies on Mucosal Immunity Induced by Transmissible Gastroenteritis Virus Nucleocapsid Protein Recombinant in Mice and Sow.传染性胃肠炎病毒核衣壳蛋白重组体诱导小鼠和母猪黏膜免疫的研究
Agric Sci China. 2009 Feb;8(2):231-237. doi: 10.1016/S1671-2927(09)60031-6. Epub 2009 Feb 24.
2
Mucosal vaccine delivery: Current state and a pediatric perspective.黏膜疫苗递送:现状与儿科视角
J Control Release. 2016 Oct 28;240:394-413. doi: 10.1016/j.jconrel.2016.02.014. Epub 2016 Feb 6.
3
Lactic acid bacteria--20 years exploring their potential as live vectors for mucosal vaccination.
as an Effective Mucosal Vaccination Carrier: a Systematic Literature Review.
作为一种有效的黏膜疫苗接种载体:一项系统文献综述
J Microbiol Biotechnol. 2025 Mar 7;35:e2411036. doi: 10.4014/jmb.2411.11036.
4
Advancing vaccine technology through the manipulation of pathogenic and commensal bacteria.通过操纵致病细菌和共生细菌推进疫苗技术。
Mater Today Bio. 2024 Nov 16;29:101349. doi: 10.1016/j.mtbio.2024.101349. eCollection 2024 Dec.
5
M cells targeted H. pylori antigen SAM-FAdE displayed on bacterium-like particles induce protective immunity.靶向显示在类细菌颗粒上的幽门螺杆菌抗原SAM-FAdE的M细胞可诱导保护性免疫。
J Nanobiotechnology. 2025 Jan 18;23(1):23. doi: 10.1186/s12951-025-03111-9.
6
An atopic dermatitis-like murine model by skin-brushed cockroach Per a 2 and oral tolerance induction by Lactococcus lactis-derived Per a 2.经皮刷蟑螂 Per a 2 诱导的特应性皮炎样小鼠模型和乳球菌衍生的 Per a 2 口服耐受诱导。
PLoS One. 2023 Sep 7;18(9):e0291162. doi: 10.1371/journal.pone.0291162. eCollection 2023.
7
Lactococcus lactis as an Interleukin Delivery System for Prophylaxis and Treatment of Inflammatory and Autoimmune Diseases.乳球菌作为白介素传递系统在预防和治疗炎症及自身免疫性疾病中的应用。
Probiotics Antimicrob Proteins. 2024 Apr;16(2):352-366. doi: 10.1007/s12602-023-10041-1. Epub 2023 Feb 7.
8
Combined oral immunization with probiotics Entercoccus faecalis delivering surface-anchored proteins provide protective efficacies against homologous infection in chickens.联合口服免疫益生菌粪肠球菌传递表面锚定蛋白对同源感染鸡提供保护效果。
Front Immunol. 2022 Oct 13;13:1042143. doi: 10.3389/fimmu.2022.1042143. eCollection 2022.
9
Live Biotherapeutic GEN3013 Enhances Antitumor Efficacy of Cancer Treatment via Modulation of Cancer Progression and Immune System.活生物疗法GEN3013通过调节癌症进展和免疫系统增强癌症治疗的抗肿瘤疗效。
Cancers (Basel). 2022 Aug 23;14(17):4083. doi: 10.3390/cancers14174083.
10
The Complex Role of Lactic Acid Bacteria in Food Detoxification.乳酸菌在食品解毒中的复杂作用。
Nutrients. 2022 May 12;14(10):2038. doi: 10.3390/nu14102038.
乳酸菌——探索其作为黏膜疫苗活载体潜力的20年
Appl Microbiol Biotechnol. 2015 Apr;99(7):2967-77. doi: 10.1007/s00253-015-6498-0. Epub 2015 Mar 10.
4
A novel assay to measure B cell responses to keyhole limpet haemocyanin vaccination in healthy volunteers and subjects with systemic lupus erythematosus.一种新型测定方法,用于测量健康志愿者和系统性红斑狼疮患者对血蓝蛋白疫苗的 B 细胞反应。
Br J Clin Pharmacol. 2013 Aug;76(2):188-202. doi: 10.1111/bcp.12172.
5
Oral immunization with Lactococcus lactis secreting attenuated recombinant staphylococcal enterotoxin B induces a protective immune response in a murine model.口服表达减毒重组金葡菌肠毒素 B 的乳球菌可诱导小鼠产生保护性免疫应答。
Microb Cell Fact. 2013 Apr 5;12:32. doi: 10.1186/1475-2859-12-32.
6
Subcutaneous or oral immunization of mice with Lactococcus lactis expressing F4 fimbrial adhesin FaeG.用表达F4菌毛黏附素FaeG的乳酸乳球菌对小鼠进行皮下或口服免疫。
J Vet Med Sci. 2013;75(6):779-84. doi: 10.1292/jvms.12-0267. Epub 2013 Feb 6.
7
Mucosal priming of the murine immune system against enterohemorrhagic Escherichia coli O157:H7 using Lactococcus lactis expressing the type III secretion system protein EspB.利用表达III型分泌系统蛋白EspB的乳酸乳球菌对小鼠免疫系统进行黏膜致敏以抵抗肠出血性大肠杆菌O157:H7 。
Vet Immunol Immunopathol. 2013 Mar 15;152(1-2):141-5. doi: 10.1016/j.vetimm.2012.09.019. Epub 2012 Sep 26.
8
Avian reovirus sigma C enhances the mucosal and systemic immune responses elicited by antigen-conjugated lactic acid bacteria.禽呼肠孤病毒 sigma C 增强了抗原偶联乳酸杆菌诱导的黏膜和系统免疫应答。
Vaccine. 2012 Jul 13;30(33):5019-29. doi: 10.1016/j.vaccine.2012.04.043. Epub 2012 Apr 21.
9
Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity.口服免疫表达布鲁氏菌铜锌超氧化物歧化酶重组乳球菌对小鼠的保护作用。
Vaccine. 2012 Feb 8;30(7):1283-90. doi: 10.1016/j.vaccine.2011.12.088. Epub 2012 Jan 2.
10
Mucosal co-immunization of mice with recombinant lactococci secreting VapA antigen and leptin elicits a protective immune response against Rhodococcus equi infection.黏膜共免疫重组乳球菌分泌 vapA 抗原和瘦素的小鼠引发保护性免疫反应,对抗马红球菌感染。
Vaccine. 2011 Dec 9;30(1):95-102. doi: 10.1016/j.vaccine.2011.10.026. Epub 2011 Oct 20.